You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fixed dose combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)

Not yet recruiting
  • COPD
  • Ipratropium / Levosalbutamol Fixed Dose Combination
  • Ipratropium + Levosalbutamol Free Dose Combination
  • (no location specified)
Sep 13, 2023

Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)

Not yet recruiting
  • Healthy Volunteer Study
  • Fixed-Dose Combination (FDC) Tablet
  • (no location specified)
Sep 22, 2023

COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)

Not yet recruiting
  • COPD
  • Ipratropium / Levosalbutamol Fixed Dose Combination
  • Ipratropium + Levosalbutamol Free Dose Combination
  • (no location specified)
Jun 5, 2023

Postoperative Pain Trial in Seoul (Acetaminophen/Ibuprofen fixed-dose combination)

Not yet recruiting
  • Postoperative Pain
  • Acetaminophen/Ibuprofen fixed-dose combination
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 5, 2023

Postoperative Pain Trial (acetaminophen/ibuprofen fixed-dose combination, Saline)

Recruiting
  • Postoperative Pain
  • acetaminophen/ibuprofen fixed-dose combination
  • Saline
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 27, 2022

Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe

Not yet recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Bempedoic acid and/or its fixed dose combination with ezetimibe
  • (no location specified)
Mar 23, 2023

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

Efficacy of Fixed Dose Combination Therapy With Atorvastatin and

Enrolling by invitation
  • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Nov 4, 2022

    FDC, Diabetes, Type 2 Trial in Cheongju-si (DWC202213, DWJ1563, DWP16001)

    Recruiting
    • FDC
    • Diabetes Mellitus, Type 2
    • Cheongju-si, Seowon-gu, Korea, Republic of
      Chungbuk National University Hospital
    Feb 10, 2023

    Healthy Male Subjects Trial in Auckland, Christchurch (Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC),

    Recruiting
    • Healthy Male Subjects
    • Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC)
    • +2 more
    • Adelaide, South Australia, Australia
    • +3 more
    Feb 1, 2023

    Advanced Solid Tumors Trial in Beijing (BMS-986213)

    Recruiting
    • Advanced Solid Tumors
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2022

    Seasonal Allergic Rhinitis Trial in Toronto (Mometasone + Azelastine, Mometasone Furoate, Azelastine Hydrochloride)

    Not yet recruiting
    • Seasonal Allergic Rhinitis
    • Mometasone + Azelastine
    • +2 more
    • Toronto, Ontario, Canada
      Sandoz Investigational Site
    May 24, 2023

    PD-L1-selected Solid Tumors Trial in Spokane (Tiragolumab and Atezolizumab IV FDC)

    Recruiting
    • PD-L1-selected Solid Tumors
    • Tiragolumab and Atezolizumab IV FDC
    • Spokane, Washington
      Medical Oncology Associates
    Jan 13, 2023

    Rhinitis Allergic Trial (Fexofenadine HCL and pseudoephedrine HCL)

    Not yet recruiting
    • Rhinitis Allergic
    • Fexofenadine HCL and pseudoephedrine HCL
    • (no location specified)
    Jan 31, 2023

    Cystic Fibrosis Trial (VX-121/TEZ/D-IVA)

    Not yet recruiting
    • Cystic Fibrosis
    • (no location specified)
    Sep 7, 2022

    Effectiveness, and Safety ofFixed-dose Combination of

    Not yet recruiting
    • Plaque Psoriasis
    • CAL/BDP PAD Cream
    • (no location specified)
    Mar 31, 2023

    Type 2 Diabetes Trial in India (dapagliflozin and saxagliptin)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • dapagliflozin and saxagliptin
    • Bangalore, India
    • +8 more
    Jan 17, 2023

    Healthy Trial in Merksem (FDC of macitentan/tadalafil (10 mg/20 mg), Macitentan 10 mg, Tadalafil 20 mg)

    Completed
    • Healthy
    • FDC of macitentan/tadalafil (10 mg/20 mg)
    • +2 more
    • Merksem, Belgium
      Clinical Pharmacology Unit
    Sep 13, 2022

    Type 2 Diabetes Trial in Seoul (Irbesartan/atorvastatin fixed dose combination, Irbesartan SR47436, Atorvastatin)

    Completed
    • Type 2 Diabetes Mellitus
    • Irbesartan/atorvastatin fixed dose combination
    • +2 more
    • Seoul, Korea, Republic of
      Korea
    Apr 5, 2022

    OSA Trial (AD109, Placebo)

    Not yet recruiting
    • OSA
    • (no location specified)
    Apr 12, 2023

    Healthy Trial in Salt Lake City (Macitentan 10 mg, Tadalafil 20 mg, Macitentan 10 mg/Tadalafil 20mg FDC)

    Completed
    • Healthy
    • Macitentan 10 mg
    • +2 more
    • Salt Lake City, Utah
      PRAHS
    May 24, 2022

    OSA Trial (AD109, Placebo)

    Not yet recruiting
    • OSA
    • (no location specified)
    Apr 13, 2023

    Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg

    Not yet recruiting
    • Type2diabetes
    • Insulin Resistance
    • (no location specified)
    Oct 20, 2022

    Asthma Trial in United States (TEV-56248, Albuterol sulfate)

    Recruiting
    • Asthma
    • Westminster, California
    • +8 more
    Sep 28, 2023

    Pain, Acute Trial in Valinhos (Fixed Dose Combination, Etodolac, Cyclobenzaprine)

    Recruiting
    • Pain, Acute
    • Fixed Dose Combination
    • +2 more
    • Valinhos, São Paulo, Brazil
      Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.
    Apr 19, 2022